Viewing Study NCT03351361


Ignite Creation Date: 2025-12-24 @ 12:09 PM
Ignite Modification Date: 2026-05-31 @ 1:10 PM
Study NCT ID: NCT03351361
Status: COMPLETED
Last Update Posted: 2023-03-01
First Post: 2017-11-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Nivolumab and Ipilimumab Versus Chimiotherapy in First Line Treatment in PS 2 or Elderly in Advanced NSCLC Patients
Sponsor: Rennes University Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module